‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal

‘Lets take it to the Aussies’: inside Ebos’s ‘revolutionary’ $1.1 billion deal
Rewind to 2013. Ebos’s chief executive, Mark Waller (right), and Symbion’s chief executive, Patrick Davies, come together to mark a $1.1b transaction. (Image: NZME)
Rebecca Stevenson
In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly voted for a $1.1 billion acquisition of pharmaceutical company Symbion, or Zuellig Healthcare Holdings Australia. This deal gave rise to a tagline Ebos still references today, as the largest diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It made Ebos then the third-largest listed company on the NZX, and a dual listing on the ASX followed la...

More Markets

Monthly CPI tech takes Stats NZ into the future
Economy

Monthly CPI tech takes Stats NZ into the future

Budget funding for new inflation-reporting tech is a giant leap forward, agency says.

Fonterra leads NZ sharemarket rise
Markets Market Close

Fonterra leads NZ sharemarket rise

The NZX 50 grew by 0.15% to 12,480.05 as Fonterra performed well.

Tom Raynel 26 Jun 2025
NZ sharemarket flat despite export growth
Markets Market close

NZ sharemarket flat despite export growth

The NZ sharemarket dipped as Fletcher Building shares fell further.

Tom Raynel 25 Jun 2025
FMA to focus on private market offers
Markets

FMA to focus on private market offers

The FMA is worried about unsophisticated investors taking the bait.

Pattrick Smellie 25 Jun 2025